Can first trimester placental protein-13 and pregnancy-associated plasma protein-A predict pre-eclampsia in Turkish women?

References

• ACOG. 2002. Practice Bulletin. Diagnosis and management of preeclampsia and eclampsia. Obstetrics and Gynecology 99:159.
   Google Scholar
• Akolekar R, Syngelaki A, Beta J, Kocylowski R, Nicolaides KH. 2009. Maternal serum placental protein 13 at 11–13 weeks of gestation in preeclampsia. Prenatal Diagnosis 29:1103–1108.
   PubMed Web of Science ®Google Scholar
• Bonno M, Oxvig C, Kephart GM, Wagner JM, Kristensen T, Sottrup-Jensen L et al. 1994. Localization of pregnancy-associated plasma protein-A and colocalization of pregnancy-associated plasma protein-A messenger ribonucleic acid and eosinophil granule major basic protein messenger ribonucleic acid in placenta. Laboratory Investigation 71: 560–566.
   PubMed Web of Science ®Google Scholar
• Burger O, Pick E, Zwickel J, Klayman M, Meiri H, Slotky R et al. 2004. Placental protein 13 (PP-13): effects on cultured trophoblasts, and its detection in human body fluids in normal and pathological pregnancies. Placenta 25:608–622.
   PubMed Web of Science ®Google Scholar
• Cowans NJ, Spencer K, Meiri H. 2008. First-trimester maternal placental protein 13 levels in pregnancies resulting in adverse outcomes. Prenatal Diagnosis 28:121–125.
   PubMed Web of Science ®Google Scholar
• Hauth JC, Ewell MG, Levine RJ, Esterlitz JR, Sibai B, Curet LB et al. 2000. Pregnancy outcomes in healthy nulliparas who developed hypertension. Calcium for preeclampsia prevention study group. Obstetrics and Gynecology 95:24–28.
   Google Scholar
• Huppertz B, Sammar M, Chefetz I, Neumaier-Wagner P, Bartz C, Meiri H. 2008. Longitudinal determination of serum placental protein 13 during development of preeclampsia. Fetal Diagnosis and Therapy 24:230–236.
   PubMed Web of Science ®Google Scholar
• Khalil A, Cowans NJ, Spencer K, Goichman S, Meiri H, Harrington K. 2009. First trimester maternal serum placental protein 13 for the prediction of pre-eclampsia in women with a priori high risk. Prenatal Diagnosis 29:781–789.
   PubMed Web of Science ®Google Scholar
• Khalil A, Cowans NJ, Spencer K, Goichman S, Meiri H, Harrington K. 2010. First-trimester markers for the prediction of pre-eclampsia in women with a-priori high risk. Ultrasound in Obstetrics and Gynecology 35:671–679.
   PubMed Web of Science ®Google Scholar
• Lawrence JB, Oxvig C, Overgaard MT, Sottrup-Jensen L, Gleich GJ, Hays LG et al. 1999. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proceedings of the National Academy of Sciences of the United States of America 96:3149–3153.
   Google Scholar
• Nicolaides KH, Bindra R, Turan OM, Chefetz I, Sammar M, Meiri H et al. 2006. A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound. Ultrasound in Obstetrics and Gynecology 27:13–17.
   PubMed Web of Science ®Google Scholar
• Odegård RA, Vatten LJ, Nilsen ST, Salvesen KA, Austgulen R. 2000. Preeclampsia and fetal growth. Obstetrics and Gynecology 96: 950–955.
   PubMed Web of Science ®Google Scholar
• Pilalis A, Souka AP, Antsaklis P, Daskalakis G, Papantoniou N, Mesogitis S, Antsaklis A. 2007. Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11–14 weeks’ gestation. Ultrasound in Obstetrics and Gynecology 29:135–140.
   PubMed Web of Science ®Google Scholar
• Prefumo F, Sebire NJ, Thilaganathan B. 2004. Decreased endovascular trophoblast invasion in first trimester pregnancies with high-resistance uterine artery Doppler indices. Human Reproduction 19:206–209.
   PubMed Web of Science ®Google Scholar
• Schneuer FJ, Nassar N, Khambalia AZ, Tasevski V, Guilbert C, Ashton AW et al. 2012. First trimester screening of maternal placental protein 13 for predicting preeclampsia and small for gestational age: in-house study and systematic review. Placenta 33:735–740.
   PubMed Web of Science ®Google Scholar
• Spencer K, Cowans NJ, Chefetz I, Tal J, Meiri H. 2007. First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia. Ultrasound in Obstetrics and Gynecology 29:128–134.
   PubMed Web of Science ®Google Scholar
• Than NG, Abdul Rahman O, Magenheim R, Nagy B, Fule T, Hargitai B et al. 2008. Placental protein 13 (galectin-13) has decreased placental expression but increased shedding and maternal serum concentrations in patients presenting with preterm pre-eclampsia and HELLP syndrome. Virchows Archives 453:387–400.
   PubMed Web of Science ®Google Scholar
• Than NG, Pick E, Bellyei S, Szigeti A, Burger O, Berente Z et al. 2004. Functional analyses of placental protein 13/galectin-13. European Journal of Biochemistry 271:1065–1078.
   PubMedGoogle Scholar
• von Dadelszen P, Magee LA, Roberts JM. 2003. Subclassification of preeclampsia. Hypertension in Pregnancy 22:143–148.
   PubMed Web of Science ®Google Scholar